Clinical Trials Browser

Anatomic Stage II Breast Cancer AJCC v8 × trastuzumab biosimilar HLX02 × 90 days × Clear all

NCT04266249 2026-03-02

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

Phase 2 Active not recruiting

Anatomic Stage II Breast Cancer AJCC v8